Sol Green, PhD, FACB
- Director, Clinical Process Optimization and Global Technical Services, BD Diagnostics, Preanalytical Systems
Assistant Clinical Professor, Department of Pathology, Stony Brook School of Medicine, Stony Brook, New York
Stephen Church, BEng, PgD, MICR
- Associate Director, Medical Affairs, BD Diagnostics, Preanalytical Systems, Europe
- Member, EFLM Working Group on the Preanalytical Phase (WG-PRE)
Member, ISO Working Group on Standardization of Specimen Containers
Member, Institute of Clinical Research
Stephen has more than 20 years’ experience in the design and development of medical devices. He has supported numerous hospitals throughout Europe in making significant improvements to the preanalytical phase and laboratory services. Stephen has published a number of articles and given presentations at scientific meetings on various topics key to the preanalytical phase, such as plasma vs. serum in biochemistry testing, the importance of preanalytical handling, etc.
Ana Stankovic, MD, PhD, MSPH
- Worldwide Vice President, Medical Affairs, BD Diagnostics, Preanalytical Systems
- M.D. and Ph.D. in Immunology from the University of Belgrade, Yugoslavia
- MSPH – Health Policy and Outcomes Research, University of Alabama at Birmingham
- Board certified in Clinical Pathology and Blood Banking/Transfusion Medicine by the American Board of Pathology
- Associate Clinical Professor, Department of Pathology, Vanderbilt University, School of Medicine, Nashville, Tennessee
- Member, College of American Pathologists’ Quality Practices Subcommittee
- Former Medical Officer at the Centers for Disease Control and Prevention, and Pathologist at Quest Diagnostics, Inc.
Ana completed her senior Fulbright fellowship, residency in Clinical Pathology, fellowship training in Blood Banking and Transfusion Medicine and MS in Public Health at the University of Alabama at Birmingham. She is the author of numerous publications and is currently focusing her research interests on the improvement in the quality of laboratory testing and increasing awareness of the impact of the preanalytical phase on clinical results.
- Associate Director – Global Alliance Management and Preanalytical Services, BD Diagnostics, Preanalytical Systems, Canada
Karen has played an active role in clinical diagnostic practices for over 30 years, as laboratory technologist, technical specialist, and educator, as well as in sales and marketing functions. Her commitment to assisting healthcare professionals clarify/ prioritize issues and implement solutions has significantly enhanced the “best practices” and “performance excellence” focus of BD reanalytical Services. Karen has worked closely with instrument companies and managers at all levels within hospitals and reference labs to design, develop and implement sustainable preanalytical improvement programs which assist laboratories in identifying the cost of, and articulating the impact of poor specimen quality to patients, and organizationally.
Adarsh Pal Singh, PhD
- Director, Medical Affairs, BD Diagnostics, Preanalytical Systems, South & Central Asia Pacific
- Member, Corporate Council of APFCB
Adarsh has several years' experience in laboratory diagnostics. During the last years, he has been instrumental in driving preanalytical quality awareness throughactively working with various laboratory professionals, associations, and key opinion leaders across south and central Asia Pacific. He designed and implemented various preanalytical improvement tools in the region. He also led studies to find the impact of devices and method of blood collection on specimen quality.
He has been the technical lead for the BD-PEPFAR program on Safe Blood Collection through in-country capability-building in Kenya, Zambia and Tanzania. In the Asia Pacific Region, Adarsh has been leading initiatives towards phlebotomy education in India and Southeast Asia.